| 0 |
Notes |
Mar. 31, 2025 |
|
Dec. 31, 2024 |
| |
|
|
|
|
| Assets |
|
|
|
|
| Cash and balances at the central bank |
9 |
67,709,656 |
|
136,165,920 |
| Due from banks |
10 |
314,144,761 |
|
270,089,441 |
| Loans and advances to banks, net |
12 |
16,109,873 |
|
9,555,410 |
| Loans and advances to customers, net |
13 |
361,830,507 |
|
340,955,698 |
| Derivative financial instruments |
|
930,893 |
|
819,711 |
| Financial investments |
|
|
|
|
| - Financial Assets at Fair Value through OCI |
14 |
259,396,282 |
|
233,029,903 |
| - Financial Assets at Amortized cost |
14 |
188,018,472 |
|
167,276,956 |
| Investments in subsidiaries and associates |
15 |
853,165 |
|
871,525 |
| Non-current assets held for sale |
28 |
159,828 |
|
159,828 |
| Other assets |
16 |
40,366,933 |
|
44,175,232 |
| Deferred tax assets |
|
2,536,325 |
|
2,337,304 |
| Property and equipment |
17 |
4,597,989 |
|
3,881,620 |
| Total assets |
|
1,256,654,684 |
|
1,209,318,548 |
| Liabilities and equity |
|
|
|
|
| Liabilities |
|
|
|
|
| Due to banks |
18 |
4,051,736 |
|
2,317,715 |
| Due to customers |
19 |
996,119,565 |
|
967,895,387 |
| Derivative financial instruments |
|
78,314 |
|
100,571 |
| Current income tax liabilities |
|
5,565,862 |
|
18,327,968 |
| Other liabilities |
20 |
45,946,585 |
|
21,347,499 |
| Issued debt instruments |
21 |
5,044,951 |
|
5,067,781 |
| Other loans |
|
23,948,624 |
|
23,962,389 |
| Other provisions |
22 |
19,032,774 |
|
18,613,060 |
| Total liabilities |
|
1,099,788,411 |
|
1,057,632,370 |
| Equity |
|
|
|
|
| Issued and paid capital |
|
30,431,580 |
|
30,431,580 |
| Reserves |
|
87,850,844 |
|
63,125,912 |
| Reserve for employee stock ownership plan (ESOP) |
|
2,184,420 |
|
1,868,235 |
| Retained earnings* |
|
36,399,429 |
|
56,260,451 |
| Total equity and net profit for the period / year |
|
156,866,273 |
|
151,686,178 |
| Total liabilities and equity |
|
1,256,654,684 |
|
1,209,318,548 |
| |
|
|
## |
|
| |
|
|
|
|
| The accompanying notes are an integral part of these financial statements. |
|
|
|
|
| (Review report attached) |
|
|
|
|
| *Including net profit for the period |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
| Islam Zekry |
Hisham Ezz Al-Arab |
| Group CFO & Executive Board Member |
CEO & Executive Board Member |
| |
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| Condensed Separate Interim Income Statement for the period ended March 31, 2025 |
| |
|
Last 9 Months |
|
|
Last 9 Months |
| |
Notes |
Mar. 31, 2025 |
|
|
Mar. 31, 2024 |
| |
|
|
|
|
|
| |
|
|
|
|
|
| Interest and similar income |
|
52,299,641 |
|
|
36,544,341 |
| Interest and similar expense |
|
(27,003,143) |
|
|
(17,784,185) |
| Net interest income |
|
25,296,498 |
|
|
18,760,156 |
| |
|
|
|
|
|
| Fee and commission income |
|
3,510,324 |
|
|
2,684,283 |
| Fee and commission expense |
|
(1,586,144) |
|
|
(1,118,950) |
| Net fee and commission income |
|
1,924,180 |
|
|
1,565,333 |
| |
|
|
|
|
|
| Dividend income |
|
12,751 |
|
|
610 |
| Net trading income |
6 |
641,395 |
|
|
16,202,679 |
| Profits (Losses) on financial investments |
14.1 |
376,684 |
|
|
224,271 |
| Administrative expenses |
|
(3,748,977) |
|
|
(2,840,462) |
| Other operating income (expenses) |
7 |
(1,735,421) |
|
|
(14,923,188) |
| Impairment release (charges) for credit losses |
|
(68,528) |
|
|
(1,482,187) |
| Profit before income tax |
|
22,698,582 |
|
|
17,507,212 |
| |
|
|
|
|
|
| Income tax expense |
26 |
(6,514,216) |
|
|
(5,722,492) |
| Deferred tax assets (Liabilities) |
26 |
411,246 |
|
|
161,877 |
| Net profit for the period |
|
16,595,612 |
|
|
11,946,597 |
| |
|
|
|
|
|
| Earnings per share |
8 |
|
|
|
|
| Basic |
|
4.83 |
|
|
3.47 |
| Diluted |
|
4.79 |
|
|
3.45 |
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| 0 |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
| Islam Zekry |
Hisham Ezz Al-Arab |
| Group CFO & Executive Board Member |
CEO & Executive Board Member |
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| Condensed Separate Interim Statement of Comprehensive Income for the period ended March 31, 2025 |
Last 9 Months |
Last 9 Months |
| |
Mar. 31, 2025 |
|
Mar. 31, 2024 |
|
| |
|
|
|
|
| Net profit for the period |
16,595,612 |
|
11,946,597 |
|
| |
|
|
|
|
| Net change on financial assets at fair value through comprehensive income after tax |
2,141,325 |
|
1,977,715 |
|
| Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income |
841,407 |
|
745,406 |
|
| Total comprehensive income for the period |
19,578,344 |
|
14,669,718 |
|
| |
|
|
|
| |
|
|
|
| Condensed Separate Interim Cash Flows for the period ended March 31, 2025 |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
Notes |
Mar. 31, 2025 |
Mar. 31, 2024 |
| |
|
|
|
| Cash flow from operating activities |
|
|
|
| Profit before income tax |
|
22,698,582 |
17,507,212 |
| Adjustments to reconcile profits to net cash provided by operating activities |
|
|
|
| Fixed assets depreciation |
17 |
353,476 |
261,427 |
| Impairment release/charge for credit losses (Loans and advances to customers and banks) |
|
(1,099,420) |
1,772,387 |
| Other provisions release/charge |
22 |
317,074 |
40,759 |
| Impairment release/charge for credit losses (due from banks) |
|
144,661 |
(53) |
| Impairment release/charge for credit losses (financial investments) |
|
1,023,287 |
(290,147) |
| Impairment release/charge for other assets |
|
- |
(4,782) |
| Exchange revaluation differences for financial assets at fair value through OCI and AC |
|
212,785 |
(17,328,576) |
| Revaluation differences impairment charge for Financial Assets at Fair value through OCI |
|
(13,337) |
1,130,412 |
| Revaluation differences impairment charge for Financial Assets at Amortized cost |
|
1,240 |
95,225 |
| Revaluation differences impairment charge for due from banks |
|
- |
101 |
| Net utilized / recovered of other provisions |
22 |
(520) |
(4,517) |
| Exchange revaluation differences of other provisions |
22 |
103,160 |
3,574,794 |
| Profits/losses from selling property and equipment |
|
(6,006) |
- |
| Profits/losses from selling financial investments at fair value through OCI |
14.1 |
(195,124) |
(224,271) |
| Profits/losses from selling investments in associates |
14.1 |
(181,560) |
- |
| Share based payments |
|
316,185 |
300,000 |
| Operating profits before changes in operating assets and liabilities |
|
23,674,483 |
6,829,971 |
| |
|
|
|
| Net decrease / increase in assets and liabilities |
|
|
|
| Due from banks |
|
121,695,741 |
42,289,034 |
| Financial assets at fair value through P&L |
|
- |
(974,297) |
| Derivative financial instruments |
|
(142,036) |
154,638 |
| Loans and advances to banks and customers |
|
(26,329,852) |
(36,747,889) |
| Other assets |
|
6,045,337 |
(5,850,432) |
| Due to banks |
18 |
1,734,021 |
(6,855,319) |
| Due to customers |
19 |
28,224,178 |
117,099,122 |
| Current income tax obligations paid |
|
(948,354) |
(276,723) |
| Other liabilities |
|
5,716,835 |
1,851,912 |
| Net cash generated from (used in) operating activities |
|
159,670,353 |
117,520,017 |
| |
|
|
|
| Cash flow from investing activities |
|
|
|
| Proceeds from sale of investments in associates |
|
226,698 |
4,782 |
| Payments for investment in subsidiaries |
|
(140,000) |
- |
| Payments for purchases of property, equipment and branches construction |
|
(3,193,660) |
(366,618) |
| Proceeds from selling property and equipment |
|
6,006 |
- |
| Proceeds from redemption of financial assets at amortized cost |
|
2,537,401 |
285,507 |
| Payments for purchases of financial assets at amortized cost |
|
(23,457,385) |
(53,240,480) |
| Payments for purchases of financial assets at fair value through OCI |
|
(29,004,342) |
(26,284,875) |
| Proceeds from selling financial assets at fair value through OCI |
|
6,057,967 |
26,380,625 |
| Net cash generated from (used in) investing activities |
|
(46,967,315) |
(53,221,059) |
| |
|
|
|
| |
|
Mar. 31, 2025 |
Mar. 31, 2024 |
| |
|
|
|
| Cash flow from financing activities |
|
|
|
| Other loans |
|
(13,765) |
6,700,881 |
| Dividends paid |
|
(14,160,152) |
(5,078,792) |
| Issued debt instruments |
|
(22,830) |
1,626,167 |
| Net cash generated from (used in) financing activities |
|
(14,196,747) |
3,248,256 |
| |
|
|
|
| Net (decrease) increase in cash and cash equivalent during the period |
|
98,506,291 |
67,547,214 |
| Beginning balance of cash and cash equivalent |
|
227,028,744 |
233,912,193 |
| Cash and cash equivalent at the end of the period |
|
325,535,035 |
301,459,407 |
| |
|
|
|
| Cash and cash equivalent comprise: |
|
|
|
| Cash and balances at the central bank |
9 |
67,709,656 |
36,542,863 |
| Due from banks |
|
314,289,639 |
291,980,200 |
| Treasury bills and other governmental notes |
11 |
115,964,828 |
119,754,167 |
| Obligatory reserve balance with CBE |
|
(43,718,398) |
(19,383,018) |
| Due from banks with maturity more than three months |
|
(14,867,792) |
(7,554,480) |
| Treasury bills and other governmental notes with maturity more than three months |
|
(113,842,898) |
(119,880,325) |
| Total cash and cash equivalent |
|
325,535,035 |
301,459,407 |
|
|
|
|
| |
|
|
|
| |
|
|
|
| Condensed Separate Interim statement of changes in shareholders' equity |
| |
Issued and paid capital |
Legal reserve |
General reserve |
General risk reserve |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Total |
| Mar. 31, 2024 |
|
|
|
|
|
|
|
|
|
|
| Beginning Balance at 1 January 2024 |
30,195,010 |
4,770,354 |
39,840,707 |
1,549,445 |
21,155 |
(16,808,265) |
15,230 |
29,230,360 |
1,486,010 |
90,300,006 |
| Transferred to reserves |
- |
1,438,320 |
21,958,960 |
- |
1,663 |
- |
- |
(23,398,943) |
- |
- |
| Dividend paid |
- |
- |
- |
- |
- |
- |
- |
(5,366,429) |
- |
(5,366,429) |
| Net profit for the period |
- |
- |
- |
- |
- |
- |
- |
11,946,597 |
- |
11,946,597 |
| Net change on financial assets at fair value through OCI after tax |
- |
- |
- |
- |
- |
1,977,715 |
- |
- |
- |
1,977,715 |
| Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
2,694 |
(2,694) |
- |
- |
| Effect of ECL in fair value of debt instruments measured at fair value through OCI |
- |
- |
- |
- |
- |
745,406 |
- |
- |
- |
745,406 |
| Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
300,000 |
300,000 |
| Balance at 31 March 2024 |
30,195,010 |
6,208,674 |
61,799,667 |
1,549,445 |
22,818 |
(14,085,144) |
17,924 |
12,408,891 |
1,786,010 |
99,903,295 |
| |
|
|
|
|
|
|
|
|
|
|
| |
| |
Issued and paid capital |
Legal reserve |
General reserve |
General risk reserve |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Total |
| Mar. 31, 2025 |
|
|
|
|
|
|
|
|
|
|
| Beginning Balance at 1 January 2025 |
30,431,580 |
6,208,674 |
62,422,792 |
1,549,445 |
22,818 |
(7,095,741) |
17,924 |
56,260,451 |
1,868,235 |
151,686,178 |
| Transferred to reserves |
- |
2,771,284 |
18,971,298 |
- |
2,246 |
- |
- |
(21,744,828) |
- |
- |
| Dividends paid |
- |
- |
- |
- |
- |
- |
- |
(14,714,434) |
- |
(14,714,434) |
| Net profit for the period |
- |
- |
- |
- |
- |
- |
- |
16,595,612 |
- |
16,595,612 |
| Net change on financial assets at fair value through OCI after tax |
- |
- |
- |
- |
- |
2,141,325 |
- |
- |
- |
2,141,325 |
| Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
(2,628) |
2,628 |
- |
- |
| Effect of ECL in fair value of debt instruments measured at fair value through OCI |
- |
- |
- |
- |
- |
841,407 |
- |
- |
- |
841,407 |
| Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
316,185 |
316,185 |
| Balance at 31 March 2025 |
30,431,580 |
8,979,958 |
81,394,090 |
1,549,445 |
25,064 |
(4,113,009) |
15,296 |
36,399,429 |
2,184,420 |
156,866,273 |
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
| |
|
| |
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|